Non-Opioid Pain Management Solutions in Orlando, FL

non opioid pain management for a city of 250k–500k — without a fake storefront

If a sales sheet cannot tell you that Orlando is JN (First Coast Service Options) and that adult diabetes here is 11.2% (PLACES 2023), it is selling units, not a program. That is the non opioid pain management conversation we actually have.

The chart problems we still see in FL

• Adult arthritis here is 19.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 16.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Florida.
• Medicare wound-care biologics in Florida are paid under First Coast Service Options (JN). CTP and skin-substitute LCDs are MAC-specific — a protocol that billed cleanly in another jurisdiction can stall here if documentation does not match JN coverage articles.
• First Coast (Florida) is the only single-state MAC; every other state shares a contractor with neighbors. Florida is JN — copy-pasting a Florida LCD packet here is a denial pattern we still see.

Why we will not invent a Orlando diabetes rate

16.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 307,573 residents will still mix those payers. CDC PLACES (2023, crude) estimates 11.2% of adults in Orlando have diagnosed diabetes — 0.8 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.

Do this before you expand SKUs